Skye Bioscience, Inc. , a clinical-stage biotechnology company, focuses on developing molecules that modulate G-protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases.
Skye Bioscience stock last closed at $1.99, down 2.45% from the previous day, and has decreased 93.89% in one year. It has underperformed other stocks in the Biotechnology industry by 0.79 percentage points. Skye Bioscience stock is currently +21.34% from its 52-week low of $1.64, and -95.02% from its 52-week high of $39.92.
As of Sep 14, 2026, there are 4.43M shares of SKYE outstanding. The market capitalization of SKYE is $8.81M. In the last 24 hours, 54,000 SKYE shares were traded.
You need a brokerage account to access the NASDAQ market and buy SKYE shares.
In our opinion, eToro is the best place to buy stocks. Here's why:
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountNow that you've picked your brokerage, the next step is to fill out some personal details so you can buy SKYE today.
Now that you have filled out your info on our top ranked stock trading app, you can securely and quickly fund your account:
Check out the walkthrough below for more details depositing money into your brokerage account.
After you have selected the best place to buy Skye Bioscience stock, it's crucial to analyze their stock prior to investing, so you can understand the risk as well as the opportunity.
WallStreetZen was designed to help part-time investors do better fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on SKYE's stock page.
Investors use a variety of different financial metrics, analyses, models, and charts to gauge SKYE's fair value.
You can access more valuation analysis on SKYE's stock here.
You can dive deeper into what analysts are saying on the Skye Bioscience stock forecast page.
In the past year, insiders at SKYE have sold more shares than they have bought.
5am Partners VII LLC, 10% Owner of SKYE, was the latest SKYE insider to sell. They sold $370.88 worth of SKYE shares on Aug 20, 2026.
Learn more about who owns SKYE stock here.
No, Skye Bioscience doesn't provide an income stream by paying out dividends.
One of the reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other traders have to say.
There are two main order types:
Click the Open button and your broker will place the order.
If you require additional help buying stocks on eToro, watch the helpful video below:
Now that you own some shares in SKYE, you'll want to stay up-to-date on your company.
Create a watchlist to keep track of your SKYE stock.
To reiterate, here are the 6 steps for buying Skye Bioscience stock:
If you need a place to buy stocks, eToro is our favorite option.
Get Started with eToro TodayIf you would like to get updates on your investment in Skye Bioscience, click below.